![Corazon Sanders](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 7 M $ in data 31/07/2026
Corazon Dating Sanders is currently Director at AbGenomics International, Inc., Independent Director at Ultragenyx Pharmaceutical, Inc., Independent Director at Legend Biotech Corp., Director at AltruBio, Inc., Independent Director at Calidi Biotherapeutics, Inc., and Trustee at Fred Hutchinson Cancer Research Center.
Former positions include Director at Fred Hutchinson Cancer Research Center, Director at Transcelerate Biopharma, Inc., Independent Director at Molecular Templates, Inc. from 2019 to 2024, Independent Non-Executive Director at BeOne Medicines Ltd. from 2020 to 2026, Senior Vice President & Global Head-PD Innovation at Genentech, Inc. from 2012 to 2017, and Executive Vice President-Development Operations at Juno Therapeutics, Inc. from 2017 to 2018.
Education includes undergraduate and graduate degrees from the University of the Philippines and graduate and doctorate degrees from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,01% | 11/06/2026 | 149.175 ( 0,01% ) | 4 M $ | 31/07/2026 |
| 26/11/2025 | 57.226 ( 0,05% ) | 2 M $ | 31/07/2026 | |
| 15/06/2026 | 21.095 ( 0,02% ) | 525 476 $ | 31/07/2026 | |
LEGEND BIOTECH CORP. 0,01% | 18/03/2026 | 40.577 ( 0,01% ) | 376 352 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Direttore/Membro del Consiglio | 01/05/2020 |
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore/Membro del Consiglio | 29/06/2021 |
| CALIDI BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 17/06/2026 |
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical therapeutics | Direttore/Membro del Consiglio | - |
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Direttore/Membro del Consiglio | 01/03/2020 |
| Società | Posizione | Fine |
|---|---|---|
| BEIGENE LTD | Direttore/Membro del Consiglio | 11/06/2026 |
| MOLECULAR TEMPLATES, INC. | Direttore/Membro del Consiglio | 31/12/2024 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/03/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direttore Amministrativo | 29/08/2012 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical therapeutics | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
University of the Philippines
 University of the Philippines Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
